Cenit

쎄니트 · 037760

Materials Steel · KOSDAQ

Small-cap

Market cap US$60.6M (₩83.6B)

Overview

Cenit is a diversified Korean company listed on KOSDAQ, the country's tech and small-cap exchange, operating across four distinct businesses: manufacturing stainless-steel sheet, running cinema theatres, supplying ready-mix concrete and aggregates, and testing pharmaceutical products for quality compliance.

Its stainless-steel sheet, thin, precision-rolled material used across various industries, is supplied to domestic customers as well as buyers in Europe, North America, and Japan. Steel and concrete together account for the largest share of its business activity, while pharmaceutical testing is a smaller but growing segment.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$92M

▼ −4.1% YoY

Operating profit · FY2025

−US$785.1K

Turned to loss

Net income · FY2025

−US$4.3M

Loss widened

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$101.7M(₩140.4B)	US$96M(₩132.4B)	US$92M(₩127B)
Operating profit	US$3.6M(₩4.9B)	US$2.4M(₩3.3B)	−US$785.1K(−₩1.1B)
Net income	US$2.8M(₩3.8B)	−US$533.3K(−₩735.9M)	−US$4.3M(−₩5.9B)

Revenue

FY2023US$101.7M
FY2024US$96M
FY2025US$92M

Operating profit

FY2023US$3.6M
FY2024US$2.4M
FY2025−US$785.1K

Net income

FY2023US$2.8M
FY2024−US$533.3K
FY2025−US$4.3M

Key ratios (FY2025)

ROE

-6.0%

Debt/Eq

127.5%

Op. margin

-0.8%

Net margin

-4.7%

Rev. YoY

▼ −4.1%

Why it matters

Its pharmaceutical-testing subsidiary, 파마엔텍, is pursuing approval as a testing body for cosmetics and medical devices, which would expand the scope of that division.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?